NCT00211510View on ClinicalTrials.gov

Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

February 28, 2007

Conditions
Type 1 Diabetes
Interventions
DEVICE

Paradigm 722 sensor augmented pump

Subjects use the Paradigm 722 sensor augmented pump

DEVICE

Paradigm 715 insulin pump

Subjects use the Paradigm 715 insulin pump

Trial Locations (7)

12206

The Endocrine Group, Albany

30309

Atlanta Diabetes Associates, Atlanta

78229

Diabetes and Glandular Diabetes Research Associates, San Antonio

90027

Children's Hospital of Los Angeles, Los Angeles

94305

Stanford University, Stanford

98195

University of Washington, Seattle

02215

Joslin Diabetes Center, Boston

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT00211510 - Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter